Canadian Know-How: Successfully Navigating a Centralized Framework for Oncology Clinical Trial Ethical Review
Now more than ever, time is of the essence when it comes to oncology clinical trial start-up and execution. The…
Busting Myths about the Canadian Regulatory Review Process – An interview with Susanne Picard
In this interview, Susanne Picard, Founder & President of SPharm Inc., answers questions about the Canadian regulatory environment and dispels…
Impact of Clinical Trials on Cancer Patient Outcomes
Those of us who work in clinical operations and oncology drug development can sometimes get caught up in the operations or science and lose sight of the impact our work can have on the lives of people battling cancer. I’d like to share one man’s story to illustrate
Tips on developing oncology biomarkers and companion diagnostics – Transcript of interview with Dr. John Reddington
The increased demand for targeted therapeutics has prompted oncology drug developers to uncover innovative solutions to new challenges. Fueled by…
Biomarkers & Companion Diagnostics – Interview with John Reddington
The increased demand for targeted therapeutics has prompted oncology drug developers to uncover innovative solutions to new challenges. Fueled by…